Jefferies Adjusts Astellas Pharma's Price Target to 1,850 Yen From 1,700 Yen, Keeps at Hold
Jefferies Adjusts Astellas Pharma's Price Target to 1,850 Yen From 1,700 Yen, Keeps at Hold
Jefferies將安斯泰萊製藥(adr)的目標價從1700日元調整爲1850日元，維持持有評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間